HOLLY REICHARDT: Open Payments
NPI 1134636293 · RAYVILLE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$609 in 27 payments from 8 companies in 2025. Trend: 2023 $195 · 2024 $574 · 2025 $609
Food & beverage: $609
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 8 | $197 |
| AstraZeneca Pharmaceuticals LP | 8 | $192 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $105 |
| Axsome Therapeutics, Inc. | 2 | $35 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $27 |
| Otsuka America Pharmaceutical, Inc. | 1 | $18 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $18 |
| Lilly USA, LLC | 1 | $16 |
Products named: QULIPTA, FARXIGA, CAPLYTA, VRAYLAR, AIRSUPRA, Auvelity, Kerendia, BREZTRI.
Industry payments across LA — which companies pay providers there.
